Americans demand Pfizer vaccine which is still a week away from FDA approval after UK decision

Give us what the Brits have got: America demands Pfizer’s COVID vaccine – which is at least a week away from FDA approval – be rolled out NOW after UK gives US firm’s shot the green light The Pfizer-BioNTech vaccine was made in the US but approved in Britain first Donald Trump has been pressuring … Read more

EVERYTHING you need to know about Pfizer’s Covid-19 vaccine

Britain’s regulators today approved Pfizer/BioNTech’s Covid vaccine, paving the way for mass-vaccination to start within days. Officials said the jab will be made available ‘from next week’ as Health Secretary Matt Hancock declared the end of the pandemic was now ‘in sight’. Here, MailOnline answers all the questions about the jab, including who will get … Read more

Coronavirus vaccine from Pfizer and BioNTech approved by regulators in the UK for roll out in days

Pfizer’s coronavirus vaccine is APPROVED by regulators for use in UK and could be rolled out across the country NEXT WEEK Department of Health announced the news just after 7am this morning It came as England came out of its second national lockdown today  The Pfizer vaccine will reportedly be given staff first due to … Read more

Coronavirus vaccine from Pfizer and BioNTech has been approved by regulators for use in the UK an…

Coronavirus vaccine from Pfizer and BioNTech has been approved by regulators for use in the UK and will roll out NEXT WEEK By Dan Sales For Mailonline Published: 07:10 GMT, 2 December 2020 | Updated: 07:11 GMT, 2 December 2020 A Covid-19 vaccine from Pfizer/BioNTech has been approved by the Medicines and Healthcare products Regulatory … Read more

Coronavirus UK: Regulator is poised to give go-ahead to a vaccine for emergency use within DAYS

The UK medicines regulator is posed to license one of the coronavirus vaccines for emergency use within days as the Armed Forces and the NHS urgently start preparing for its distribution at around 10 ‘vaccine hubs’.  Military personnel are transforming locations including the mothballed Nightingale hospital at London’s ExCel centre, Epsom racecourse in Surrey, and … Read more

NHS volunteers who signed up to help shielders in April will be trained to DELIVER Covid-19 vaccine

NHS army of volunteers who signed up to help shielders in April will be trained to deliver Covid-19 vaccines as soon as one is approved More than 750,000 answered the health services call for aid in the pandemic And today it was revealed they would be enlisted to administer a Covid-19 jab The vaccine could … Read more

Nearly 40% of healthcare workers say they are ‘not likely’ to get a coronavirus vaccine

Nearly 40% of healthcare workers say it’s ‘not likely’ they will get a coronavirus vaccine because they are afraid the jabs were developed too quickly to be safe A recent CDC survey found that 37% of healthcare workers say they were ‘not likely’ to get the coronavirus vaccine Only 21% were ‘absolutely certain’ with the … Read more

Why no vaccine can ever be 100% effective

The announcement of not one but three coronavirus vaccines has been widely welcomed, in particular, their effectiveness. Preliminary results of clinical trials into the three jabs show their effectiveness — how good they are at stopping people from getting Covid symptoms — varies from 62 per cent to 95 per cent.  The news that none of … Read more

Novavax delays US trials for COVID vaccine and says late-stage study will begin ‘in coming weeks’

Novavax delays US trials for its coronavirus vaccine AGAIN and says late-stage study will begin ‘in the coming weeks’ as it struggles to scale up production of its jab Novovax delayed the start of its late-stage US trials for the second time after initially declaring a start date in October and then November The company said … Read more

Coronavirus: Moderna to submit vaccine for emergency approval

Moderna will today submit its Covid vaccine for emergency approval in the US and Europe, after the final analysis of its last-stage trial showed that the jab is 94.1 per cent effective at preventing infection. Results from the Massachusetts-based company’s stage three trials mark a landmark success for the vaccine, with the firm’s chief executive … Read more